Gwiazda Jane E, Hyman Leslie, Norton Thomas T, Hussein Mohamed E M, Marsh-Tootle Wendy, Manny Ruth, Wang Ying, Everett Donald
New England College of Optometry, Boston, Massachusetts 02115, USA.
Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2143-51. doi: 10.1167/iovs.03-1306.
To examine baseline measurements of accommodative lag, phoria, reading distance, amount of near work, and level of myopia as risk factors for progression of myopia and their interaction with treatment over 3 years, in children enrolled in the Correction of Myopia Evaluation Trial (COMET).
COMET enrolled 469 ethnically diverse children (ages, 6-11 years) with myopia between -1.25 and -4.50 D. They were randomly assigned to either progressive addition lenses (PALs) with a +2.00 addition (n = 235) or single vision lenses (SVLs; n = 234), the conventional spectacle treatment, and were observed for 3 years. The primary outcome measure was progression of myopia by autorefraction after cycloplegia with 2 drops of 1% tropicamide. Other measurements included accommodative response (by an open field of view autorefractor), phoria (by cover test), reading distance, and hours of near work. Independent and interaction analyses were based on the mean of the two eyes. Results were adjusted for important covariates with multiple linear regression.
Children with larger accommodative lags (>0.43 D for a 33 cm target) wearing SVLs had the most progression at 3 years. PALs were effective in slowing progression in these children, with statistically significant 3-year treatment effects (mean +/- SE) for those with larger lags in combination with near esophoria (PAL - SVL progression = -1.08 D - [-1.72 D] = 0.64 +/- 0.21 D), shorter reading distances (0.44 +/- 0.20 D), or lower baseline myopia (0.48 +/- 0.15 D). The 3-year treatment effect for larger lags in combination with more hours of near work was 0.42 +/- 0.26 D, which did not reach statistical significance. Statistically significant treatment effects were observed in these four groups at 1 year and became larger from 1 to 3 years.
The results support the COMET rationale (i.e., a role for retinal defocus in myopia progression). In clinical practice in the United States children with large lags of accommodation and near esophoria often are prescribed PALs or bifocals to improve visual performance. Results of this study suggest that such children, if myopic, may have an additional benefit of slowed progression of myopia.
在近视矫正评估试验(COMET)中,研究调节滞后、隐斜视、阅读距离、近工作时长及近视程度等基线测量指标作为近视进展的风险因素,以及它们在3年期间与治疗的相互作用。
COMET招募了469名年龄在6至11岁、近视度数在-1.25至-4.50 D之间的不同种族儿童。他们被随机分配到加光+2.00的渐进多焦点镜片(PALs,n = 235)组或单光镜片(SVLs,n = 234)组,后者为传统的眼镜治疗方式,并对他们进行了3年的观察。主要结局指标是在使用2滴1%托吡卡胺散瞳后通过自动验光仪测量的近视进展情况。其他测量指标包括调节反应(通过开放式视野自动验光仪)、隐斜视(通过遮盖试验)、阅读距离和近工作时长。独立分析和交互分析基于双眼的平均值。结果通过多元线性回归对重要协变量进行了校正。
佩戴SVLs且调节滞后较大(注视33 cm目标时>0.43 D)的儿童在3年时近视进展最多。PALs对减缓这些儿童的近视进展有效,对于调节滞后较大且伴有内隐斜视(PAL - SVL进展=-1.08 D - [-1.72 D]=0.64±0.21 D)、阅读距离较短(0.44±0.20 D)或基线近视程度较低(0.48±0.15 D)的儿童,具有统计学显著的3年治疗效果。调节滞后较大且近工作时长较多的儿童3年治疗效果为0.42±0.26 D,未达到统计学显著性。在这四组中,1年时观察到了统计学显著的治疗效果,且从1年到3年效果增大。
研究结果支持了COMET的理论依据(即视网膜离焦在近视进展中的作用)。在美国的临床实践中,调节滞后较大且有内隐斜视的儿童常被开具PALs或双焦点镜片以改善视觉表现。本研究结果表明,这类近视儿童可能会额外受益于减缓的近视进展。